PEMETREXED TEVA RTU 25 MGML

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

PEMETREXED

Доступна з:

ABIC MARKETING LTD, ISRAEL

Код атс:

L01BA04

Фармацевтична форма:

CONCENTRATE FOR SOLUTION FOR INFUSION

Склад:

PEMETREXED 25 MG / 1 ML

Адміністрація маршрут:

I.V

Тип рецепту:

Required

Виробник:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Терапевтична области:

PEMETREXED

Терапевтичні свідчення:

Pemetrexed Teva RTU in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Pemetrexed Teva RTU in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva RTU is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva RTU is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

Дата Авторизація:

2018-01-03